Michael A Ihnat

Title: Michael A Ihnat: Innovator in Cancer Research

Introduction

Michael A Ihnat is a notable inventor based in Tuttle, OK (US). He has made significant contributions to the field of cancer research, particularly in developing methods to identify compounds that target suppressed cancer cells. With a total of 2 patents, his work is paving the way for advancements in cancer treatment.

Latest Patents

Michael's latest patents include innovative methods for identifying compounds that can effectively target suppressed cancer cells. One of his patents focuses on in vivo methods of identifying these compounds, which involves co-injecting labeled cancer cells with a malignant-phenotype suppressing matrix into a test animal. This method aims to produce suppressed micrometastatic cells for further study. Another patent details in vitro methods that compare the response of cancer cells grown on different support matrices, allowing researchers to identify compounds capable of targeting these suppressed cells.

Career Highlights

Michael A Ihnat is affiliated with the University of Oklahoma, where he continues to contribute to cancer research. His work is characterized by a commitment to understanding the complexities of cancer cell behavior and developing targeted therapies. His innovative approaches have garnered attention in the scientific community.

Collaborations

Michael collaborates with esteemed colleagues such as Robert E Hurst and Kimberly D Kyker. Their combined expertise enhances the research efforts at the University of Oklahoma, fostering an environment of innovation and discovery.

Conclusion

Michael A Ihnat's contributions to cancer research through his patents and collaborations highlight his dedication to improving treatment options for patients. His innovative methods are crucial in the ongoing fight against cancer, showcasing the importance of targeted therapies in modern medicine.